teclistamab
genmab,janssen
['multiplemyeloma', 'teclistamab', 'mmsm']
#teclistamab led to deep and durable responses after approximately 2 years of follow-up in patients with #multiplemyeloma regardless of refractory status. #mmsm #eha2023 
Oncology news and insights from leading researchers and cancer centers.